DiaSorin, Inc. · Class II · Cleared Feb 18, 2021
| K-number | K202574 |
| Device name | LIAISON Lyme IgG, LIAISON Lyme IgG Control Set, LIAISON Lyme Total Antibody Plus |
| Applicant | DiaSorin, Inc. |
| Product code | LSR |
| Device class | Class II |
| Decision date | Feb 18, 2021 |
| Decision | Substantially Equivalent |
| Regulation | 866.3830 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov